{"id":13855,"date":"2024-01-26T14:29:24","date_gmt":"2024-01-26T14:29:24","guid":{"rendered":"https:\/\/nhcoa.org\/es\/?p=13855"},"modified":"2024-01-26T14:36:47","modified_gmt":"2024-01-26T14:36:47","slug":"jn-1-la-nueva-subvariante-de-covid-19","status":"publish","type":"post","link":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/","title":{"rendered":"JN.1: la nueva Subvariante de COVID-19"},"content":{"rendered":"\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63-1024x576.png\" alt=\"\" class=\"wp-image-13853\" style=\"width:550px\" srcset=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63-980x551.png 980w, https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63-480x270.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-acf3c585636d08a1dc4f34a488d631d6 wp-block-paragraph\" style=\"font-size:15px\"><strong>La subvariante JN.1, derivada de la variante BA.2.86, es la m\u00e1s reciente variante desarrollada del virus de COVID-19. <\/strong>Apareci\u00f3 por primera vez en estudios realizados en M\u00e9xico y se identific\u00f3 en paralelo en Luxemburgo y Estados Unidos a finales de agosto de 2023. Posteriormente, se localizaron diagn\u00f3sticos en Europa y China.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"has-black-color has-text-color has-link-color wp-elements-c4d9b2db69c686170c3e5e5b192b2434 wp-block-paragraph\" style=\"font-size:15px\">Desde el 19 de diciembre de 2023, la Organizaci\u00f3n Mundial de la Salud (OMS) clasific\u00f3 a JN.1 como una variante de inter\u00e9s, es decir, que tiene caracter\u00edsticas con el potencial para aumentar la transmisibilidad o la gravedad de la enfermedad. Sin embargo, los Centros para el Control y la Prevenci\u00f3n de Enfermedades (CDC, por sus siglas en ingl\u00e9s) aseguran que actualmente no hay evidencia de que JN.1 cause una enfermedad m\u00e1s grave y el riesgo para la salud p\u00fablica es bajo. <\/p>\n<\/blockquote>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-bfebda42e8a184cc2cf694b0e976b214 wp-block-paragraph\" style=\"font-size:15px\">Por otra parte, los CDC indican que el <strong>COVID-19 sigue siendo \u201cuna amenaza grave para la salud p\u00fablica\u201d<\/strong>, sobre todo para poblaciones vulnerables con mayor riesgo de enfermarse a un nivel grave, como los adultos mayores, los beb\u00e9s, las personas con sistemas inmunitarios debilitados o padecimientos de salud cr\u00f3nicos, as\u00ed como las mujeres embarazadas.<br><strong>Las nuevas caracter\u00edsticas de esta subvariante de Omicr\u00f3n son que se contagia con mayor facilidad y tiene la habilidad de evadir el sistema inmunitario mejor que otras variantes.<\/strong> A pesar de su mayor capacidad de transmisi\u00f3n, seg\u00fan los expertos en los CDC, hasta el momento no afecta el aumento en los casos graves.<br>En referencia a los s\u00edntomas,<strong> la JN.1 se manifiesta con mayor frecuencia a trav\u00e9s de estornudos, rinitis y tos. En algunos casos, la aparici\u00f3n de dolor de garganta y fiebre puede ser asociado con esta nueva subvariante. <\/strong>Por su parte, la p\u00e9rdida del olfato y del gusto, s\u00edntomas caracter\u00edsticos en los primeros contagios, ya no forman parte de los cuadros t\u00edpicos de coronavirus actualmente.<br>La OMS afirma que las vacunas actuales contra el COVID-19 siguen protegiendo de esta nueva variante. Al ser una subvariante de \u00d3micron, la protecci\u00f3n de estas vacunas sigue siendo efectiva. Siendo las vacunas de Pfizer y Moderna las m\u00e1s actualizadas que se tienen hasta el momento.<br>Si bien, JN.1 no representa un riesgo alto hasta el momento,<strong> las autoridades recomiendan seguir las recomendaciones generales dadas para el tratamiento y prevenci\u00f3n del COVID-19<\/strong>. Por ejemplo, estar al d\u00eda con el esquema de vacunaci\u00f3n, incluyendo las dosis actualizadas. En esta temporada de enfermedades respiratorias, se vuelve imprescindible el uso de mascarilla en \u00e1reas cerradas o poco ventiladas. As\u00ed como mantener una distancia segura entre personas; lavarse las manos con regularidad, ventilar las \u00e1reas del hogar para hacer circular mejor el aire.<br>Es importante practicar estas recomendaciones sin olvidar que podemos proteger a los dem\u00e1s cuid\u00e1ndonos a nosotros mismos,<strong> se recomienda hacerse una prueba si presenta s\u00edntomas, o si podr\u00eda haber estado expuesto a alguien con COVID-19 o gripe y, en caso de estar enfermo, quedarse en casa de 5 a 7 d\u00edas hasta que desaparezcan los s\u00edntomas.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-16868167dddb9591dd6418c84ebc9727 wp-block-paragraph\" style=\"font-size:15px\"><strong>References:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.cdc.gov\/respiratory-viruses\/whats-new\/JN.1-update-2024-01-05.html\">https:\/\/www.cdc.gov\/respiratory-viruses\/whats-new\/JN.1-update-2024-01-05.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/conecta.tec.mx\/es\/noticias\/nacional\/salud\/sintomas-y-rasgos-de-la-nueva-subvariante-de-covid-jn1-pirola\">https:\/\/conecta.tec.mx\/es\/noticias\/nacional\/salud\/sintomas-y-rasgos-de-la-nueva-subvariante-de-covid-jn1-pirola<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.eltiempo.com\/salud\/que-se-sabe-de-la-nueva-variante-jn-1-del-coronavirus-covid-19-841352\">https:\/\/www.eltiempo.com\/salud\/que-se-sabe-de-la-nueva-variante-jn-1-del-coronavirus-covid-19-841352<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.reuters.com\/world\/us\/cdc-says-jn1-variant-accounts-about-62-covid-cases-us-2024-01-05\/\">https:\/\/www.reuters.com\/world\/us\/cdc-says-jn1-variant-accounts-about-62-covid-cases-us-2024-01-05\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La subvariante JN.1, derivada de la variante BA.2.86, es la m\u00e1s reciente variante desarrollada del virus de COVID-19. Apareci\u00f3 por primera vez en estudios realizados en M\u00e9xico y se identific\u00f3 en paralelo en Luxemburgo y Estados Unidos a finales de agosto de 2023. Posteriormente, se localizaron diagn\u00f3sticos en Europa y China. Desde el 19 de [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":13853,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"yes","footnotes":""},"categories":[9],"tags":[59,58,19,201,202],"class_list":["post-13855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-coronavirus","tag-covid","tag-covid-19","tag-omicron","tag-subvariante"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>JN.1: la nueva Subvariante de COVID-19 - NHCOA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JN.1: la nueva Subvariante de COVID-19 - NHCOA\" \/>\n<meta property=\"og:description\" content=\"La subvariante JN.1, derivada de la variante BA.2.86, es la m\u00e1s reciente variante desarrollada del virus de COVID-19. Apareci\u00f3 por primera vez en estudios realizados en M\u00e9xico y se identific\u00f3 en paralelo en Luxemburgo y Estados Unidos a finales de agosto de 2023. Posteriormente, se localizaron diagn\u00f3sticos en Europa y China. Desde el 19 de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"NHCOA\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-26T14:29:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-26T14:36:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"nhcoa_media\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"nhcoa_media\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/\"},\"author\":{\"name\":\"nhcoa_media\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"headline\":\"JN.1: la nueva Subvariante de COVID-19\",\"datePublished\":\"2024-01-26T14:29:24+00:00\",\"dateModified\":\"2024-01-26T14:36:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/\"},\"wordCount\":565,\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Blog-header-63.png\",\"keywords\":[\"coronavirus\",\"covid\",\"covid-19\",\"omicron\",\"subvariante\"],\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/\",\"name\":\"JN.1: la nueva Subvariante de COVID-19 - NHCOA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Blog-header-63.png\",\"datePublished\":\"2024-01-26T14:29:24+00:00\",\"dateModified\":\"2024-01-26T14:36:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/jn-1-la-nueva-subvariante-de-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JN.1: la nueva Subvariante de COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\",\"name\":\"NHCOA\",\"description\":\"Improving lives of hispanic and latino older adults.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\",\"name\":\"nhcoa_media\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/author\\\/nhcoa_media\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"JN.1: la nueva Subvariante de COVID-19 - NHCOA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"JN.1: la nueva Subvariante de COVID-19 - NHCOA","og_description":"La subvariante JN.1, derivada de la variante BA.2.86, es la m\u00e1s reciente variante desarrollada del virus de COVID-19. Apareci\u00f3 por primera vez en estudios realizados en M\u00e9xico y se identific\u00f3 en paralelo en Luxemburgo y Estados Unidos a finales de agosto de 2023. Posteriormente, se localizaron diagn\u00f3sticos en Europa y China. Desde el 19 de [&hellip;]","og_url":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/","og_site_name":"NHCOA","article_published_time":"2024-01-26T14:29:24+00:00","article_modified_time":"2024-01-26T14:36:47+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63.png","type":"image\/png"}],"author":"nhcoa_media","twitter_card":"summary_large_image","twitter_misc":{"Written by":"nhcoa_media","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#article","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/"},"author":{"name":"nhcoa_media","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"headline":"JN.1: la nueva Subvariante de COVID-19","datePublished":"2024-01-26T14:29:24+00:00","dateModified":"2024-01-26T14:36:47+00:00","mainEntityOfPage":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/"},"wordCount":565,"image":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63.png","keywords":["coronavirus","covid","covid-19","omicron","subvariante"],"articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/","url":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/","name":"JN.1: la nueva Subvariante de COVID-19 - NHCOA","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2024\/01\/Blog-header-63.png","datePublished":"2024-01-26T14:29:24+00:00","dateModified":"2024-01-26T14:36:47+00:00","author":{"@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"breadcrumb":{"@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nhcoa.org\/es\/jn-1-la-nueva-subvariante-de-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhcoa.org\/es\/"},{"@type":"ListItem","position":2,"name":"JN.1: la nueva Subvariante de COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/nhcoa.org\/es\/#website","url":"https:\/\/nhcoa.org\/es\/","name":"NHCOA","description":"Improving lives of hispanic and latino older adults.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhcoa.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890","name":"nhcoa_media","url":"https:\/\/nhcoa.org\/es\/author\/nhcoa_media\/"}]}},"_links":{"self":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/comments?post=13855"}],"version-history":[{"count":3,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13855\/revisions"}],"predecessor-version":[{"id":13860,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13855\/revisions\/13860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media\/13853"}],"wp:attachment":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media?parent=13855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/categories?post=13855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/tags?post=13855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}